journal article·2016-01-02

Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders

Madhulika Pradhan, Deependra Singh, Manju Rawat Singh

Publisher page

Abstract

Aim of the study was to develop solid lipid nanoparticles (SLN) of triamcinolone acetonide (TA) and to study the effect of various process variables in order to optimize the formulation for effective delivery. Drug loaded SLNs were successfully prepared and characterized by TEM, XRD and DSC study. Process variables like surfactant concentration, drug concentration, lipid concentration etc. showed significant effect on the particle size and entrapment efficiency. SLNs exhibited prolonged drug release following Higuchi release kinetics (R(2) = 0.9909). In vitro skin distribution study demonstrated systemic escape of drug from TA loaded SLNs which might eliminate side effects associated with systemic exposure.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pharmaceutical Biotechnology Laboratory, University Institute of Pharmacy, Pt. Ravishankar Shukla University

References (33)

Show source-provided references
1. 10.3109/10837450.2013.76326110.3109/10837450.2013.763261 ↗
2. 10.1016/j.jconrel.2005.09.05210.1016/j.jconrel.2005.09.052 ↗
3. 10.1016/j.colsurfb.2011.07.03610.1016/j.colsurfb.2011.07.036 ↗
4. 10.1016/j.ejps.2012.05.01010.1016/j.ejps.2012.05.010 ↗
5. 10.1016/j.ijpharm.2011.12.03710.1016/j.ijpharm.2011.12.037 ↗
6. 10.3109/10837450.2011.59816110.3109/10837450.2011.598161 ↗
7. 10.3109/21691401.2014.89352310.3109/21691401.2014.893523 ↗
8. 10.1016/j.ejps.2012.07.00610.1016/j.ejps.2012.07.006 ↗
9. 10.1016/j.ijpharm.2010.09.00710.1016/j.ijpharm.2010.09.007 ↗
10. 10.1016/j.chemphyslip.2013.07.01010.1016/j.chemphyslip.2013.07.010 ↗
11. Khurana S, Jain NK, Bedi PMS. 2013b. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam Life Sci. 93: 763–772.
12. Lason E, Sikora E, Ogonowski J. 2013. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation. Acta Biochemica Polonica. 60:773–777.
13. 10.1016/j.ijpharm.2006.08.00710.1016/j.ijpharm.2006.08.007 ↗
14. 10.1016/j.eurpolymj.2004.09.01510.1016/j.eurpolymj.2004.09.015 ↗
15. 10.1016/j.ijpharm.2008.08.01310.1016/j.ijpharm.2008.08.013 ↗
16. 10.1007/s11095-006-0143-710.1007/s11095-006-0143-7 ↗
17. 10.1016/j.ijpharm.2011.05.00810.1016/j.ijpharm.2011.05.008 ↗
18. Mulla JS, Khazi IM. 2009. Influence of process variables on particle size of solid lipid nanoparticles. Ind J Novel Drug Deliv. 1:47–49.
19. 10.3109/21691401.2014.90982010.3109/21691401.2014.909820 ↗
20. 10.1016/j.ejps.2006.04.01610.1016/j.ejps.2006.04.016 ↗
21. 10.1016/j.jconrel.2013.05.02010.1016/j.jconrel.2013.05.020 ↗
22. 10.1016/j.addr.2011.01.01210.1016/j.addr.2011.01.012 ↗
23. 10.1208/pt080411610.1208/pt0804116 ↗
24. Samein LH. 2014. Preparation and evaluation of nystatin loaded- solid-lipid nanoparticles for topical delivery. Int J Pharm Pharm Sci. 6:592–597.
25. 10.1016/j.addr.2007.04.00610.1016/j.addr.2007.04.006 ↗
26. 10.1517/17425247.2012.74584810.1517/17425247.2012.745848 ↗
27. 10.3109/21691401.2014.88340110.3109/21691401.2014.883401 ↗
28. Singh M, Singh D, Saraf S. 2011. Influence of selected formulation variables on the preparation of peptide loaded lipospheres. Trends Med Res 6:863–876.
29. 10.2174/15672011280038912410.2174/156720112800389124 ↗
30. 10.1016/j.ejps.2009.04.00810.1016/j.ejps.2009.04.008 ↗
31. 10.1016/S0168-3659(01)00432-110.1016/S0168-3659(01)00432-1 ↗
32. 10.4314/tjpr.v13i5.110.4314/tjpr.v13i5.1 ↗
33. 10.1016/j.colsurfb.2010.12.02410.1016/j.colsurfb.2010.12.024 ↗